Equity
€100 from €129,672 in 2022
Equity fell by 100% in 3 years.
DR. WECKX WOUTER
Lifetime
6 annual accounts with figures on one time axispeak €128,927 (2025)
€128,927▲ 17.5%
peak €87,192 (2025)
€87,192▲ 9.1%
peak €129,672 (2022)
€100unchanged
€136,634▲ 14.7%
Board1 name since 2020
1 director
Documentsfilings and deeds
02-03-2026151 days before the deadline
2025micro format
Gross margin from €109,736 to €128,927Registered office moved within Rotselaar 06-06Dividend €87,192Cash from €65,903 to €92,944
Key points
from the 2025 annual accountsTurnover
≈ €230,000 estimated
The micro format states no turnover.
Debts
€136,634 100% of the balance sheet
Financial debts 22%Suppliers 1%Taxes and wages 5%Other 71%
Of this, €106,095 falls due within a year.
Filings
6 annual accounts since 2020
The last five annual accounts were filed 31 to 151 days before the end of the period.
Starting capital
€100 100 shares
Position in the sector
0.1%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,334 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as DR. WECKX WOUTER has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for DR. WECKX WOUTER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved within Rotselaar
New registered office: Kwikstaartweg 34 te 3110 Rotselaar · Previous registered office: Beukenlaan 39 te 3110 Rotselaar · General meeting of 01-04-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0753515301
Registered office moved from Leuven to Rotselaar
New registered office: Beukenlaan 39 te 3110 Rotselaar · Previous registered office: Armand Meyswijk 1 te 3012 Leuven · General meeting of 06-08-2021 · Gazette deed
Incorporation
Founding capital of €100, 100 shares · Founder: · Appointment: (director) · published on 03-09-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. WECKX WOUTER Rotselaar | €136,734 | €128,927 | 0.1% | - |
| DEHA Medical Dilbeek | €142,374 | €128,429 | 86.1% | - |
| Toon Van Hoof Boortmeerbeek | €120,363 | €127,010 | 36.9% | 0 |
| Dokter Deckers Dries Bekkevoort | €141,701 | €119,969 | 61.8% | - |
| HUISARTSEN TWEEWATERS Leuven | €162,643 | €127,216 | 7.3% | - |
| Dokter Tom Van Bouwel Heusden-Zolder | €133,728 | €127,721 | 27.5% | - |
| Jasmin Peeters Mortsel | €137,519 | €120,008 | 64.7% | - |
These companies have the same main activity as DR. : general medical practice (NACE 86210). They are comparable in size and age: total assets between €120,000 and €163,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 01-09-2020Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Establishment unit
- 2.306.799.9563110 Rotselaar, since 01-09-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 14-10-2024
Annual accounts 2025
- €136,734▲ 14.7%
- Filing
- Filed on 02-03-2026, 151 days before the end of the filing period
Insights on DR. WECKX WOUTER
DR. files the micro format. That format states no turnover. The gross margin rose from €20,240 in 2020 to €128,927 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. WECKX WOUTER
- What is the company number of DR. WECKX WOUTER?
- The company number of DR. is 0753.515.301. The VAT number is the same number with BE in front: BE 0753.515.301.
- Where is DR. WECKX WOUTER based?
- The registered office is at Kwikstaartweg 34, 3110 Rotselaar.Company details
- What does DR. WECKX WOUTER do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of DR. WECKX WOUTER?
- DR. is a private limited company (BV).
- When was DR. WECKX WOUTER founded?
- DR. was founded on 01-09-2020.
- Is DR. WECKX WOUTER still active?
- Yes, DR. is an active enterprise in the KBO register.
- What is the turnover of DR. WECKX WOUTER?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €128,927 and 30 comparable companies (NACE 86210). It probably lies between €190,000 and €290,000. In financial year 2021 turnover was €174,934.Financials
- Is DR. WECKX WOUTER profitable?
- In financial year 2025, DR. made a profit of €87,192.
- Where can I find the annual accounts of DR. WECKX WOUTER?
- DR. filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. WECKX WOUTER due?
- DR. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.